Intuitive Surgical Sees 23% Q1 Revenue Growth to $2.77B
Intuitive Surgical reported Q1 revenue up 23% to $2.77B, with recurring revenue representing 86%, while margin headwinds from oil and memory prices loom. US Da Vinci bariatrics procedures fell about 10% due to GLP-1 drug uptake, and a Q1 cybersecurity breach exposed some data without disrupting operations.
1. Q1 Financial Results
Intuitive Surgical delivered revenue of $2.77B in Q1, up 23% year-over-year, with recurring revenue also up 23% to represent 86% of total sales. The company noted that higher oil and memory prices are expected to exert a modest unfavorable impact on gross margins for the remainder of the year.
2. Procedure Trends
US Da Vinci bariatrics procedures declined approximately 10%, attributed to increased use of GLP-1 therapies. Management highlighted emerging opportunities in appendectomy procedures and modest initial upside from new reimbursable procedures in Japan, though market sizing remains preliminary.
3. Cybersecurity Incident
A cyber event in Q1 allowed unauthorized access to certain customer and employee data but did not interrupt surgical operations or device performance. The company is addressing the breach and enhancing cybersecurity measures to safeguard data integrity.
4. AI and ROSE Strategy
CEO outlined a digital roadmap leveraging AI on surgical data and electronic medical records to improve outcomes and efficiency. The ROSE acquisition is expected to enhance lung cancer diagnosis, with further details to be shared as development progresses.